Article Text

Download PDFPDF
Infection with extensively drug-resistant Shigella sonnei harbouring blaCTX-M-27 in a gay man in Italy
  1. Angelo Roberto Raccagni1,
  2. Virginia Batignani2,
  3. Alma Zinola2,
  4. Francesca Saluzzo1,2,
  5. Federico Di Marco2,
  6. Antonella Castagna1,3,
  7. Daniela Maria Cirillo1,2,
  8. Silvia Nozza1,3
  1. 1Vita-Salute San Raffaele University, Milan, Italy
  2. 2Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
  3. 3Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
  1. Correspondence to Dr Angelo Roberto Raccagni; raccagni.angelo{at}hsr.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Outbreaks of Shigella sonnei and Shigella flexneri have been reported recently among gay, bisexual and other men who have sex with men (GBMSM), with transmission linked to sexual contact, particularly practices that involve oral-anal contact or faecal-oral exposure.1–8 The emergence of extensively drug-resistant (XDR) S. sonnei harbouring plasmid-encoded blaCTX-M-27 has raised concerns about the potential spread of this extended-spectrum beta-lactamase (ESBL)-producing gene.4–7 Two ESBL+ Shigella strains have been reported in Italy, one in a 10-year-old girl returning from Albania (2018) and one in a hospitalised patient (2021, no epidemiological or clinical data available).9 10

We present the case of a 35-year-old gay man diagnosed with XDR S. sonnei at our centre in Milan in February 2024. The individual was receiving HIV pre-exposure prophylaxis (PrEP) and doxycycline post-exposure prophylaxis (DoxyPEP). Past medical history included three episodes of gonorrhoeal proctitis, one chlamydial proctitis, a syphilis diagnosis and the detection of rectal HPV DNA. He travelled frequently within and outside of Italy. He presented following the acute onset of afebrile profuse mucous and fatty diarrhoea with tenesmus. He described condomless anal-receptive and oral-anal sexual intercourse with >50 partners in the previous month, including 20 days prior to the onset of symptoms with a man visiting Milan from the UK. The man later disclosed an untreated Shigella infection. On the initial presentation, he was treated empirically with a single dose of tinidazole 2 …

View Full Text

Footnotes

  • Handling editor Anna Maria Geretti

  • Contributors ARR and SN attended clinically to the individual and contributed to the writing of the manuscript. FS designed the study and contributed to the writing of the manuscript. VB performed laboratory microbiologic analyses on the sample and contributed to the writing of the manuscript. AZ performed bioinformatic analyses and contributed to the writing of the manuscript. DMC supervised the laboratory microbiological analyses and reviewed the manuscript. FDM supervised the bioinformatic analyses and reviewed the manuscript. AC supervised the clinical activities and reviewed the manuscript. SN acted as guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.